Celltech’s month-long HOPE campaign to benefit local breast cancer patients
QUINCY — Locally-owned Celltech Electronics will be raising money during Breast Cancer Awareness Month, Oct. 1-31, to benefit local breast cancer patients. Funds raised during this month-long campaign will be distributed equally in early November to the QMG Foundation Oncology Patient Assistance Fund and to the Blessing Breast Center.
The campaign anchors around a custom-designed Celltech Cares HOPE tee with a graphic including the traditional breast cancer pink awareness ribbon incorporated into the word HOPE. It will be available at all Celltech locations for $20. The tee, offered in pink or white, was produced at locally-owned Landmarx.
“We decided to offer this tee as a way for those impacted by breast cancer to have a way to express hope,” Celltech owner Katrina Wellman said in a press release. “It’s a fabulous tee, with classic quality and style to be worn over and over again.
“Celltech is underwriting the cost, so every dollar from these tees will directly benefit local breast cancer patients. We are excited to partner with our communities to bring this opportunity to make a difference in the lives of local breast cancer patients.”
Celltech also will feature a special 2022 collection of breast cancer pink accessories and will donate 20 percent of the profit from the sale of these products to the campaign totals.
“Eligible items in the stores will each be marked with a special breast cancer pink ribbon, making it quick and easy for customers to choose from among items included in the campaign,” Wellman said.
Details are available at all six area Celltech locations starting Oct. 1. Updates will be posted on Celltech’s social media pages.
Celltech operates two stores in Quincy plus stores in Canton (Mo.), Jerseyville (Ill.), Pittsfield (Ill.),
and Rushville (Ill.).
Miss Clipping Out Stories to Save for Later?
Click the Purchase Story button below to order a print of this story. We will print it for you on matte photo paper to keep forever.